CN115445059B - Automatic guiding balloon catheter and use method thereof - Google Patents
Automatic guiding balloon catheter and use method thereof Download PDFInfo
- Publication number
- CN115445059B CN115445059B CN202211258540.0A CN202211258540A CN115445059B CN 115445059 B CN115445059 B CN 115445059B CN 202211258540 A CN202211258540 A CN 202211258540A CN 115445059 B CN115445059 B CN 115445059B
- Authority
- CN
- China
- Prior art keywords
- balloon
- catheter
- outer tube
- distal end
- traction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 50
- 229940079593 drug Drugs 0.000 claims abstract description 40
- 230000003902 lesion Effects 0.000 claims abstract description 28
- 230000000149 penetrating effect Effects 0.000 claims abstract 3
- 230000008569 process Effects 0.000 claims description 12
- 230000002787 reinforcement Effects 0.000 claims description 6
- 230000002792 vascular Effects 0.000 claims description 6
- 238000003466 welding Methods 0.000 claims description 5
- 239000004677 Nylon Substances 0.000 claims description 3
- 239000004952 Polyamide Substances 0.000 claims description 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 3
- 229920001778 nylon Polymers 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- -1 polysiloxane Polymers 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 210000005077 saccule Anatomy 0.000 abstract 2
- 238000012856 packing Methods 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 description 11
- 239000000463 material Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 229930012538 Paclitaxel Natural products 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229960001592 paclitaxel Drugs 0.000 description 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 2
- 229960002930 sirolimus Drugs 0.000 description 2
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000011982 device technology Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10181—Means for forcing inflation fluid into the balloon
- A61M25/10183—Compressible bulbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M2025/0175—Introducing, guiding, advancing, emplacing or holding catheters having telescopic features, interengaging nestable members movable in relations to one another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/32—General characteristics of the apparatus with radio-opaque indicia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
技术领域Technical Field
本申请涉及医疗器械技术领域,具体而言,涉及一种自动导向球囊导管及使用方法。The present application relates to the field of medical device technology, and in particular to an automatic guided balloon catheter and a method of use thereof.
背景技术Background Art
目前上市的药物球囊导管,球囊囊体部分都呈圆柱形,根据球囊的大小及长度分为不同的规格,药物经喷涂工艺均匀的覆盖在球囊的表面上。The drug-eluting balloon catheters currently on the market all have cylindrical balloon bodies, which are classified into different specifications according to the size and length of the balloon. The drug is evenly covered on the surface of the balloon through a spraying process.
在球囊表面上喷涂药物的种类有紫杉醇以及亲水性物质,药物喷涂后需经过折叠,再装上保护套,对球囊上的药物进行保护防止脱落。但是在手术操作过程中,需要摘下保护套,球囊上的药物是完全暴露在外的,在摘下的同时会有少量的药物掉落。The types of drugs sprayed on the balloon surface include paclitaxel and hydrophilic substances. After the drugs are sprayed, they need to be folded and then installed with a protective cover to protect the drugs on the balloon from falling off. However, during the operation, the protective cover needs to be removed, and the drugs on the balloon are completely exposed. When the protective cover is removed, a small amount of drugs will fall off.
在实际操作中,需要使用具体规格的导引导管,在导引导丝的引导下建立血管通路,将导引导管在导引导丝引导下推送至心脏冠脉病变处,选择目标血管治疗位置。准备球囊导管,排空导管内的空气,导管沿特定导引导丝经导引导管建立的血管通路到达目标血管治疗位置。球囊导管在导引导管中沿导引导丝的引导下推送至病变位置时,会有血液的冲洗,以及在推送时对导管壁的触碰都会使球囊上的药物损失。真正到达病变处的药物很少,绝大部分都损失掉了,医生操作的时间快慢也会影响到达病变位置的药量。In actual operation, it is necessary to use a guide catheter of specific specifications, establish a vascular access under the guidance of a guide guide wire, push the guide catheter to the coronary artery lesion under the guidance of the guide guide wire, and select the target vascular treatment position. Prepare the balloon catheter, evacuate the air in the catheter, and the catheter reaches the target vascular treatment position along the specific guide wire through the vascular access established by the guide catheter. When the balloon catheter is pushed to the lesion site in the guide catheter along the guide wire, there will be blood flushing, and touching the catheter wall during pushing will cause the loss of medicine on the balloon. Very little medicine actually reaches the lesion, and most of it is lost. The speed of the doctor's operation will also affect the amount of medicine reaching the lesion site.
综上所述,原有的药物球囊在操作及输送过程中会有大量药物损失掉,到达病变处的药物大大减少。In summary, a large amount of drug will be lost during the operation and delivery of the original drug balloon, and the amount of drug reaching the lesion is greatly reduced.
发明内容Summary of the invention
本申请的目的是提供一种自动导向球囊导管及使用方法,能够通过自动导向包裹型球囊的形式,将喷涂在球囊表面上的药物进行紧密包裹,并在病变部位有效地释放药物,在降低药物损失的同时改善了治疗效果。The purpose of the present application is to provide an automatically guided balloon catheter and a method of use, which can tightly wrap the drug sprayed on the surface of the balloon in the form of an automatically guided wrapped balloon and effectively release the drug at the lesion site, thereby reducing drug loss and improving the treatment effect.
为了实现上述目的,第一方面,本发明提供了一种自动导向球囊导管,包括:外管、牵引导管以及球囊,所述牵引导管可伸缩地设置在所述外管内部且穿接在所述球囊上,所述外管的远端与所述球囊的近端连接,所述球囊呈凹陷状地包裹在所述外管中且在包裹部位的表面涂覆有药物。In order to achieve the above-mentioned objectives, in a first aspect, the present invention provides an automatic guided balloon catheter, comprising: an outer tube, a traction catheter and a balloon, wherein the traction catheter is telescopically arranged inside the outer tube and is connected to the balloon, the distal end of the outer tube is connected to the proximal end of the balloon, and the balloon is wrapped in the outer tube in a concave shape and a drug is coated on the surface of the wrapped portion.
在可选的实施方式中,所述牵引导管的远端与所述球囊的远端焊接连接,且在焊接部位设置有导管加强件。In an optional embodiment, the distal end of the traction catheter is connected to the distal end of the balloon by welding, and a catheter reinforcement is provided at the welding position.
在可选的实施方式中,所述牵引导管的远端以及所述外管的远端分别设置有显影环。In an optional embodiment, the distal end of the traction catheter and the distal end of the outer tube are respectively provided with a developing ring.
在可选的实施方式中,所述外管包括充压腔,所述充压腔与所述球囊的内部相通。In an optional embodiment, the outer tube includes a pressure-filled cavity, which communicates with the interior of the balloon.
在可选的实施方式中,所述球囊包括双层结构,外层材质为聚醚嵌段聚酰胺,内层材质包括尼龙、聚硅氧烷或聚氨酯。In an optional embodiment, the balloon comprises a double-layer structure, the outer layer material is polyether block polyamide, and the inner layer material comprises nylon, polysiloxane or polyurethane.
在可选的实施方式中,所述牵引导管包括位于内部的导丝腔,所述导丝腔贯通于整个牵引导管,且在所述球囊的远端与外部相通。In an optional embodiment, the traction catheter includes an internal guidewire cavity, the guidewire cavity runs through the entire traction catheter, and communicates with the outside at the distal end of the balloon.
在可选的实施方式中,还包括导引导丝,所述导引导丝的尾端由所述球囊的远端伸入,贯穿整个所述导丝腔后从所述牵引导管中伸出。In an optional embodiment, a guide wire is further included, wherein the tail end of the guide wire extends from the distal end of the balloon, passes through the entire guide wire cavity, and then extends out from the traction catheter.
在可选的实施方式中,所述外管与所述牵引导管之间设置有支撑环,所述支撑环包括设置在所述外管内的柔性支撑环,所述牵引导管可活动地穿接在所述支撑环上。In an optional embodiment, a support ring is provided between the outer tube and the traction catheter, the support ring comprises a flexible support ring provided inside the outer tube, and the traction catheter can be movably connected to the support ring.
在可选的实施方式中,所述牵引导管的远端与所述球囊远端的中心相接,所述外管、所述支撑环及所述牵引导管同心设置。In an optional embodiment, the distal end of the traction catheter is connected to the center of the distal end of the balloon, and the outer tube, the support ring and the traction catheter are concentrically arranged.
第二方面,本发明提供一种根据前述实施方式中任一项所述自动导向球囊导管的使用方法,包括以下步骤:In a second aspect, the present invention provides a method for using the automatic guiding balloon catheter according to any one of the aforementioned embodiments, comprising the following steps:
通过导引导丝构建血管通路;Vascular access was constructed via a guide wire;
将外管远端输送至血管内病变部位的近端侧部;Delivering the distal end of the outer tube to the proximal side of the lesion site in the blood vessel;
对球囊充压,使包裹在外管中的球囊呈滚动式外翻移动;Inflate the balloon so that the balloon wrapped in the outer tube moves in a rolling outward manner;
球囊充压膨胀后与病变部位紧密贴合,使包裹部位的药物得到暴露,并持续释放在病变部位;After the balloon is inflated and expanded, it fits tightly to the lesion, exposing the drug in the wrapped area and continuously releasing it to the lesion.
药物释放完成后,对球囊泄压,并回撤牵引导管,将泄压后的球囊拖拽进入外管;After the drug release is completed, the balloon is depressurized, and the traction catheter is withdrawn to drag the depressurized balloon into the outer tube;
回撤外管,使自动导向球囊导管整体撤除。Withdraw the outer tube to remove the automatic guided balloon catheter as a whole.
本申请中通过将外管的远端与球囊的近端连接,并将牵引导管可伸缩地设置在外管内部,并结合牵引导管穿接在球囊上的连接形式,能够使球囊在充压扩张时以球囊近端为形变基准,带动牵引导管自动向前移动,实现自动导向的充压膨胀形变。In the present application, by connecting the distal end of the outer tube with the proximal end of the balloon, and telescopically arranging the traction catheter inside the outer tube, and combining the connection form of the traction catheter being threaded onto the balloon, the balloon can be made to use the proximal end of the balloon as a deformation reference when pressurized and expanded, thereby driving the traction catheter to automatically move forward, thereby realizing automatically guided pressurized expansion deformation.
结合球囊呈凹陷状地包裹在外管中,且在包裹部位的表面涂覆药物,可以把涂覆在球囊表面上的药物紧致包裹,球囊导管在导引导丝引导下推送至病变处,在病变处经加压球囊以滚动外翻的形式向前移动,在病变处球囊撑开,使得到暴露的药物持续地释放在病变位置处,持续释放时间可以根据具体要求来控制,大大减少了药物的损失,增加了病变位置处的药物释放,能更好的达到治疗效果。The balloon is wrapped in an outer tube in a concave shape, and the surface of the wrapped part is coated with drugs, so that the drugs coated on the surface of the balloon can be tightly wrapped, and the balloon catheter is pushed to the lesion under the guidance of the guide wire. At the lesion, the pressurized balloon moves forward in the form of rolling and everting, and the balloon is expanded at the lesion, so that the exposed drugs are continuously released at the lesion position. The continuous release time can be controlled according to specific requirements, which greatly reduces the loss of drugs, increases the drug release at the lesion position, and can better achieve the treatment effect.
本申请的其他特征和优点将在随后的具体实施方式部分予以详细说明。Other features and advantages of the present application will be described in detail in the subsequent specific implementation section.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
为了更清楚地说明本申请实施例的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,应当理解,以下附图仅示出了本申请的某些实施例,因此不应被看作是对范围的限定,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他相关的附图。In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.
图1为本申请中自动导向球囊导管在充压变形前的结构示意图;FIG1 is a schematic diagram of the structure of the automatic guiding balloon catheter in the present application before being deformed by inflation;
图2为本申请中自动导向球囊导管在变形过程中的结构示意图;FIG2 is a schematic diagram of the structure of the automatic guiding balloon catheter in the present application during the deformation process;
图3为本申请中自动导向球囊导管在充压变形后的结构示意图。FIG3 is a schematic diagram of the structure of the automatic guiding balloon catheter in the present application after being deformed by inflation.
图标:icon:
1-外管;2-牵引导管;3-球囊;4-导管加强件;5-显影环;6-导引导丝;7-支撑环;8-血管;9-病变部位。1-outer tube; 2-traction catheter; 3-balloon; 4-catheter reinforcement; 5-development ring; 6-guide wire; 7-support ring; 8-blood vessel; 9-lesion site.
具体实施方式DETAILED DESCRIPTION
为使本申请实施例的目的、技术方案和优点更加清楚,下面将结合本申请实施例中的附图,对本申请实施例中的技术方案进行清楚、完整地描述。显然,所描述的实施例是本申请一部分实施例,而不是全部的实施例。通常在此处附图中描述和示出的本申请实施例的组件可以以各种不同的配置来布置和设计。In order to make the purpose, technical scheme and advantages of the embodiments of the present application clearer, the technical scheme in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are part of the embodiments of the present application, rather than all of the embodiments. The components of the embodiments of the present application described and shown in the drawings here can be arranged and designed in various different configurations.
在本申请的描述中,需要说明的是,术语“内”、“外”等指示的方位或位置关系为基于附图所示的方位或位置关系,或者是该申请产品使用时惯常摆放的方位或位置关系,仅是为了便于描述本申请和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本申请的限制。此外,术语“第一”、“第二”等仅用于区分描述,而不能理解为指示或暗示相对重要性。In the description of this application, it should be noted that the terms "inside", "outside", etc. indicate the orientation or positional relationship based on the orientation or positional relationship shown in the drawings, or the orientation or positional relationship in which the product of the application is usually placed when in use, which is only for the convenience of describing this application and simplifying the description, and does not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation on this application. In addition, the terms "first", "second", etc. are only used to distinguish the description, and cannot be understood as indicating or implying relative importance.
在本申请的描述中,还需要说明的是,除非另有明确的规定和限定,术语“设置”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以具体情况理解上述术语在本申请中的具体含义。In the description of this application, it should also be noted that, unless otherwise clearly specified and limited, the terms "disposed" and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a direct connection, or an indirect connection through an intermediate medium, or it can be the internal communication of two elements. For ordinary technicians in this field, the specific meanings of the above terms in this application can be understood according to specific circumstances.
参见图1-图3,本申请中的自动导向球囊导管,主要是通过改变球囊3在导管中的压卧形式,能够有效地对涂覆在球囊3表面的药物进行包裹,防止药物在球囊3导管输送过程中的冲刷流失。1-3 , the automatic guided balloon catheter in the present application can effectively wrap the drug coated on the surface of the balloon 3 by mainly changing the pressing form of the balloon 3 in the catheter, thereby preventing the drug from being washed away during the balloon 3 catheter delivery process.
结合牵引导管2与球囊3之间的连接,以及使外管1的远端与球囊3的近端连接,能够使球囊3在可控范围内进行形变,并且方便泄压后的球囊3通过牵引导管2回撤进入外管1,利于实现自动导向扩张以及整体球囊3导管的撤除。Combined with the connection between the traction catheter 2 and the balloon 3, and connecting the distal end of the outer tube 1 with the proximal end of the balloon 3, the balloon 3 can be deformed within a controllable range, and the balloon 3 after pressure relief can be easily withdrawn into the outer tube 1 through the traction catheter 2, which is conducive to achieving automatic guided expansion and removal of the entire balloon 3 catheter.
本发明中的自动导向球囊导管,主体结构包括外管1、牵引导管2以及球囊3,具体地,牵引导管2可自由伸缩地设置在外管1内,且以穿接在球囊3上的形式与球囊3进行连接,通过牵引导管2与球囊3之间的连接,结合在牵引导管2中的导引导丝6,能够使球囊3在导引导丝6的引导下以自动导向的形式发生膨胀形变。The automatic guided balloon catheter in the present invention has a main structure including an outer tube 1, a traction catheter 2 and a balloon 3. Specifically, the traction catheter 2 can be freely and telescopically arranged in the outer tube 1, and is connected to the balloon 3 in the form of being threaded on the balloon 3. Through the connection between the traction catheter 2 and the balloon 3, combined with the guide wire 6 in the traction catheter 2, the balloon 3 can be expanded and deformed in an automatic guided manner under the guidance of the guide wire 6.
外管1的远端与球囊3的近端连接,球囊3呈凹陷状地包裹在外管1中,具体地,在未充压形变前,牵引导管2的远端位于外管1中,且与外管1的远端至少存在一定距离,使球囊3的囊体本身呈凹陷状地包裹在外管1中,通过在包裹部位的表面涂覆药物,能够形成对涂覆药物的有效保护,防止其在输送过程中受到冲刷流失。The distal end of the outer tube 1 is connected to the proximal end of the balloon 3, and the balloon 3 is wrapped in the outer tube 1 in a concave shape. Specifically, before being pressurized and deformed, the distal end of the traction catheter 2 is located in the outer tube 1 and is at least a certain distance from the distal end of the outer tube 1, so that the balloon body of the balloon 3 itself is wrapped in the outer tube 1 in a concave shape. By coating the surface of the wrapped part with drugs, effective protection can be formed for the coated drugs to prevent them from being washed away during transportation.
球囊3上的药物可以为紫杉醇、紫杉醇及雷帕霉素的混合物、雷帕霉素及载药基质的混合物。The drug on the balloon 3 may be paclitaxel, a mixture of paclitaxel and rapamycin, or a mixture of rapamycin and a drug-carrying matrix.
球囊3在充压形变过程中,能够使其与外管1远端的连接部位为基准点,更加具体地,以球囊3近端为形变基准点,使球囊3带动牵引导管2以外翻绽放的形式翻滚展开,同时将球囊3包裹部位突出于外管1,并使涂覆在包裹部位的药物得到暴露,进一步地,通过加压膨胀使翻滚外露的球囊3表面与血管8中的病变部位9紧密贴合,将得到暴露的药物持续释放在病变部位9,有效改善血管8内硬化狭窄病变部位9的治疗效果。During the inflation and deformation process, the connection part between the balloon 3 and the distal end of the outer tube 1 can be used as a reference point. More specifically, with the proximal end of the balloon 3 as the deformation reference point, the balloon 3 drives the traction catheter 2 to roll and unfold in the form of eversion and blooming, while the wrapped part of the balloon 3 protrudes from the outer tube 1, and the drug coated on the wrapped part is exposed. Furthermore, through pressurized expansion, the rolled and exposed surface of the balloon 3 is closely fitted with the diseased part 9 in the blood vessel 8, and the exposed drug is continuously released in the diseased part 9, effectively improving the treatment effect of the hardened and narrowed diseased part 9 in the blood vessel 8.
在牵引导管2中穿接有导引导丝6,基于牵引导管2与球囊3的连接,球囊3形变的过程中带动牵引导管2沿导引导丝6不断向外管1的远端伸出,实现自动导向膨胀,并使牵引导管2伴随着球囊3以长条形气球膨胀的翻滚展开形式向前移动。A guide wire 6 is inserted into the traction catheter 2. Based on the connection between the traction catheter 2 and the balloon 3, the balloon 3 drives the traction catheter 2 to continuously extend toward the distal end of the outer tube 1 along the guide wire 6 during deformation, thereby realizing automatic guided expansion, and the traction catheter 2 moves forward along with the balloon 3 in the form of a rolling expansion of a long balloon.
为了防止球囊3过度膨胀,进一步地为了防止球囊3仅在轴向上伸展,而弱化在径向上的膨胀,牵引导管2的远端与球囊3的远端焊接连接,能够形成对球囊3膨胀长度的控制,一方面能够使球囊3形变得到可控,防止球囊3过度向前移动,有效起到牵制作用,保证球囊3在径向上的充分扩张,以使球囊3表面上的药物能够可靠地贴合在病变部位9;另一方面能够在球囊3泄压后,通过回拉牵引导管2的形式将球囊3回撤至外管1内,使整体球囊3导管能够可靠地从血管8中撤除。In order to prevent the balloon 3 from over-expanding, and further to prevent the balloon 3 from stretching only in the axial direction while weakening the expansion in the radial direction, the distal end of the traction catheter 2 is welded to the distal end of the balloon 3, which can control the expansion length of the balloon 3. On the one hand, it can make the deformation of the balloon 3 controllable and prevent the balloon 3 from moving forward excessively, effectively play a restraining role, and ensure that the balloon 3 is fully expanded in the radial direction, so that the medicine on the surface of the balloon 3 can be reliably attached to the diseased site 9; on the other hand, after the balloon 3 is depressurized, the balloon 3 can be withdrawn into the outer tube 1 by pulling back the traction catheter 2, so that the entire balloon 3 catheter can be reliably removed from the blood vessel 8.
基于上述球囊3远端与牵引导管2远端的焊接,以及牵引导管2远端与外管1的远端存在的间距,本发明中的球囊3在充压前以中空尖锥的形式容卧在外管1内,中空尖锥的尖端为球囊3远端与牵引导管2远端的连接点,中空尖锥的底部为外管1的远端,球囊3的内侧壁以及外侧壁分别构成中空尖锥的内外面。Based on the welding between the distal end of the balloon 3 and the distal end of the traction catheter 2, and the distance between the distal end of the traction catheter 2 and the distal end of the outer tube 1, the balloon 3 in the present invention lies in the outer tube 1 in the form of a hollow cone before inflation, the tip of the hollow cone is the connection point between the distal end of the balloon 3 and the distal end of the traction catheter 2, the bottom of the hollow cone is the distal end of the outer tube 1, and the inner wall and the outer wall of the balloon 3 respectively constitute the inner and outer surfaces of the hollow cone.
通过该种设置方式,能够使球囊3的外侧壁以凹陷状的形式容置在外管1中,同时使凹陷部位的球囊3面得到有效包裹,有效防止涂覆药物的外露。With this arrangement, the outer side wall of the balloon 3 can be accommodated in the outer tube 1 in a concave shape, and at the same time, the surface of the balloon 3 in the concave portion can be effectively wrapped to effectively prevent the coating drug from being exposed.
在球囊3远端与牵引导管2远端的焊接部位设置有导管加强件4,能够增强球囊3与牵引导管2之间的连接强度,防止回拉球囊3或者控制球囊3膨胀程度时对球囊3本身的结构造成破坏。A catheter reinforcement 4 is provided at the welding position between the distal end of the balloon 3 and the distal end of the traction catheter 2, which can enhance the connection strength between the balloon 3 and the traction catheter 2 and prevent damage to the structure of the balloon 3 itself when pulling back the balloon 3 or controlling the expansion degree of the balloon 3.
在其中一个实施例中,牵引导管2的远端以及外管1的远端分别设置有显影环5,能够方便定位判断。具体地,基于球囊3近端与外管1远端之间的连接,根据外管1远端显影环5的定位以及球囊3的尺寸,能够判定球囊3到达病变部位9的距离,从而保证充压前凹陷部分的球囊3在充压外翻膨胀后准确地作用在病变部位9。In one embodiment, the distal end of the traction catheter 2 and the distal end of the outer tube 1 are respectively provided with a developing ring 5, which can facilitate positioning and judgment. Specifically, based on the connection between the proximal end of the balloon 3 and the distal end of the outer tube 1, according to the positioning of the developing ring 5 at the distal end of the outer tube 1 and the size of the balloon 3, the distance of the balloon 3 to the lesion site 9 can be determined, thereby ensuring that the concave part of the balloon 3 before inflation accurately acts on the lesion site 9 after inflation and eversion expansion.
结合在牵引导管2的远端设置的显影环5,能够更加准确地判断球囊3在充压后的长度,进一步提高定位精准度,并可方便通过两个显影环5的相对位置关系,来控制牵引导管2的伸缩移动。Combined with the developing ring 5 provided at the distal end of the traction catheter 2 , the length of the balloon 3 after inflation can be determined more accurately, the positioning accuracy can be further improved, and the telescopic movement of the traction catheter 2 can be conveniently controlled through the relative position relationship of the two developing rings 5 .
本发明中的外管1内部设置有充压腔,充压腔与球囊3的内部相通,能够正常进行球囊3的充泄压操作。The outer tube 1 in the present invention is provided with a pressure-charging chamber inside, and the pressure-charging chamber is communicated with the inside of the balloon 3, so that the inflation and depressurization operations of the balloon 3 can be performed normally.
进一步地,本发明中的球囊3为双层结构,具体为外硬内软的结构组成,优选地,球囊3的内外壁一体设计,外壁为较硬的聚醚嵌段聚酰胺材质,较硬材质球囊3外壁的出发点在于,能够防止球囊3在加压过程中的过度膨胀而发生脱离规整圆柱形状的走形,以及避免加压过程中因球囊3的快速移动不受牵引导管2的牵引节制。Furthermore, the balloon 3 in the present invention is a double-layer structure, specifically a hard outer and soft inner structure. Preferably, the inner and outer walls of the balloon 3 are designed as an integrated whole, and the outer wall is made of a harder polyether block polyamide material. The purpose of making the outer wall of the balloon 3 of the harder material is to prevent the balloon 3 from over-expanding during the pressurization process and deviating from the regular cylindrical shape, and to avoid the balloon 3 from being traction-controlled by the traction catheter 2 due to rapid movement during the pressurization process.
球囊3内壁为较软的尼龙、聚硅氧烷或聚氨酯等弹性材质,相对于现有普通球囊3而言,更易在球囊3加压过程中,以更短的时间向外翻出并作用于病变位置,在药物不被血液冲刷的情况下最大限度的保证贴壁药效。The inner wall of the balloon 3 is made of a softer elastic material such as nylon, polysiloxane or polyurethane. Compared with the existing ordinary balloon 3, it is easier to turn outward and act on the lesion site in a shorter time during the pressurization of the balloon 3, and the drug efficacy is maximized without being washed away by the blood.
需要指出,球囊3外硬内软的双层结构,兼顾了更加顺利地充压形变以及节制球囊3变形过程中的膨胀走形两个因素,能够更好地在可控范围内进行膨胀变形,从而保证球囊3进行可靠地外翻绽放,以及通过规整的变形来使球囊3表面对病变部位9充分地贴合。It should be pointed out that the double-layer structure of the balloon 3, which is hard on the outside and soft on the inside, takes into account two factors: smoother inflation and deformation and control of the expansion and deformation of the balloon 3 during the deformation process. It can better expand and deform within a controllable range, thereby ensuring that the balloon 3 can be reliably everted and bloomed, and through regular deformation, the surface of the balloon 3 can fully fit the diseased area 9.
牵引导管2包括位于内部的导丝腔(图中未示出),具体地,导丝腔贯通与整个牵引导管2,并且设置在牵引导管2的轴心上,其中,导丝腔的远端开口设置在球囊3远端的正中部位,并与导管加强件4密封焊接,能够增强球囊3在变形过程中的自动导向功能。The traction catheter 2 includes a guidewire cavity (not shown in the figure) located inside. Specifically, the guidewire cavity runs through the entire traction catheter 2 and is arranged on the axis of the traction catheter 2, wherein the distal opening of the guidewire cavity is arranged in the middle of the distal end of the balloon 3 and is sealed and welded to the catheter reinforcement 4, which can enhance the automatic guiding function of the balloon 3 during the deformation process.
导丝腔的远端截止在球囊3的远端,并在球囊3远端使导丝腔与外部相通,能够使导丝从球囊3的远端伸出。具体地,在球囊3导管整体进行血管8前,导引导丝6的尾端由球囊3远端伸入,贯穿整个导丝腔后从牵引导管2中伸出。能够使整体球囊3导管在导引导丝6的引导作用下进入血管8并准确可靠地到达病变部位9。The distal end of the guidewire cavity is terminated at the distal end of the balloon 3, and the guidewire cavity is communicated with the outside at the distal end of the balloon 3, so that the guidewire can be extended from the distal end of the balloon 3. Specifically, before the balloon 3 catheter as a whole enters the blood vessel 8, the tail end of the guide wire 6 is extended from the distal end of the balloon 3, passes through the entire guidewire cavity, and then extends from the traction catheter 2. The entire balloon 3 catheter can enter the blood vessel 8 under the guidance of the guide wire 6 and accurately and reliably reach the lesion site 9.
在另一个优选的实施例中,外管1与牵引导管2之间设置有支撑环7,支撑环7包括设置在外管1内的柔性支撑环7,牵引导管2可活动地穿接在支撑环7上。通过柔性支撑环7能够使外管1与牵引导管2同心设置,保持牵引导管2在外管1内伸缩移动的可靠性。In another preferred embodiment, a support ring 7 is provided between the outer tube 1 and the traction catheter 2, and the support ring 7 includes a flexible support ring 7 provided inside the outer tube 1, and the traction catheter 2 can be movably connected to the support ring 7. The flexible support ring 7 enables the outer tube 1 and the traction catheter 2 to be arranged concentrically, and the reliability of the telescopic movement of the traction catheter 2 inside the outer tube 1 is maintained.
牵引导管2的远端与球囊3远端的中心相接,进一步地,通过将外管1、支撑环7及牵引导管2同心设置,能够使牵引导管2带动球囊3在外管1的轴心方向移动,进而能够使牵引导管2可靠地将泄压后的球囊3回撤进入外管1,利于药物释放后球囊3导管的整体撤除。The distal end of the traction catheter 2 is connected to the center of the distal end of the balloon 3. Furthermore, by concentrically arranging the outer tube 1, the support ring 7 and the traction catheter 2, the traction catheter 2 can drive the balloon 3 to move in the axial direction of the outer tube 1, and thus the traction catheter 2 can reliably withdraw the depressurized balloon 3 into the outer tube 1, which is beneficial to the overall removal of the balloon 3 catheter after drug release.
需要重点指出的是,通过本发明中的自动球囊3导管,能够将喷涂在球囊3上的药物包裹在外管1内,在医生操作及输送过程中完全避免了药物的损失,在到达病变位置时,再释放药物,药物可大部分作用于病变位置,从最大程度上保证治疗效果。It is important to point out that, through the automatic balloon 3 catheter of the present invention, the drug sprayed on the balloon 3 can be wrapped in the outer tube 1, and the loss of the drug is completely avoided during the doctor's operation and transportation process. When the drug reaches the lesion site, the drug is released and most of the drug can act on the lesion site, thereby ensuring the treatment effect to the greatest extent.
本发明还提供了一种上述自动导向球囊导管的使用方法,包括以下步骤:The present invention also provides a method for using the above-mentioned automatic guiding balloon catheter, comprising the following steps:
选用具体规格的球囊3导管,在导引导丝6的引导下建立血管8通路,摘下球囊3导管远端上的保护套,将球囊3导管在导引导丝6引导下推送至冠脉病变处,选择目标血管8治疗位置。Select a balloon 3 catheter of specific specifications, establish a blood vessel 8 access under the guidance of the guide wire 6, remove the protective cover on the distal end of the balloon 3 catheter, push the balloon 3 catheter to the coronary artery lesion under the guidance of the guide wire 6, and select the target blood vessel 8 treatment position.
将球囊3导管上外管1的远端输送至血管8内病变部位9的近端侧部,并且在外管1远端与病变部位9预留球囊3充压形变的空间。The distal end of the outer tube 1 on the balloon 3 catheter is transported to the proximal side of the diseased site 9 in the blood vessel 8, and a space for the balloon 3 to be pressurized and deformed is reserved between the distal end of the outer tube 1 and the diseased site 9.
输送过程中涂覆在球囊3表面上的药物处于包裹状态,减少了血流冲刷以及与血管8内壁触碰的流失。During the delivery process, the drug coated on the surface of the balloon 3 is in a wrapped state, which reduces the loss due to blood flow erosion and contact with the inner wall of the blood vessel 8.
对球囊3进行充压,使凹陷状包裹在外管1内的球囊3呈翻滚式向前移动突出外管1,并朝外管1远端延伸。The balloon 3 is pressurized, so that the balloon 3 wrapped in the outer tube 1 in a concave shape moves forward in a rolling manner to protrude from the outer tube 1 and extend toward the distal end of the outer tube 1 .
通过控制牵引导管2节制球囊3的过度前伸,使球囊3在径向上进行膨胀扩张并与病变部位9紧密贴合,使包裹部位的药物得到暴露,并持续释放在病变部位9。By controlling the traction catheter 2 to restrain the excessive extension of the balloon 3 , the balloon 3 is expanded in the radial direction and fits tightly with the lesion site 9 , so that the medicine in the wrapped part is exposed and continuously released at the lesion site 9 .
通过控制球囊3的充压膨胀时间,控制药物的释放时间,作用时间的长短可以根据具体情况进行判定。药物释放完成后,对球囊3泄压,并回撤牵引导管2,将泄压后的球囊3拖拽进入外管1内部。By controlling the inflation time of the balloon 3, the release time of the drug is controlled, and the duration of the action time can be determined according to the specific situation. After the drug release is completed, the balloon 3 is depressurized, and the traction catheter 2 is withdrawn to drag the depressurized balloon 3 into the outer tube 1.
回撤外管1,使自动导向球囊导管在血管8内整体撤除。The outer tube 1 is withdrawn to completely remove the automatic guiding balloon catheter from the blood vessel 8 .
通过本发明中自动导向球囊导管的使用,能够在最大程度上避免球囊3输送过程中的流失,并且有效地改善对病变部位9的治疗效果。By using the automatic guiding balloon catheter in the present invention, the loss of the balloon 3 during the delivery process can be avoided to the greatest extent, and the treatment effect on the lesion site 9 can be effectively improved.
需要说明的是,在不冲突的情况下,本申请中的实施例中的特征可以相互结合。It should be noted that, in the absence of conflict, the features in the embodiments of this application may be combined with each other.
以上所述仅为本申请的优选实施例而已,并不用于限制本申请,对于本领域的技术人员来说,本申请可以有各种更改和变化。凡在本申请的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本申请的保护范围之内。The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211258540.0A CN115445059B (en) | 2022-10-14 | 2022-10-14 | Automatic guiding balloon catheter and use method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211258540.0A CN115445059B (en) | 2022-10-14 | 2022-10-14 | Automatic guiding balloon catheter and use method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115445059A CN115445059A (en) | 2022-12-09 |
CN115445059B true CN115445059B (en) | 2024-11-08 |
Family
ID=84311578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211258540.0A Active CN115445059B (en) | 2022-10-14 | 2022-10-14 | Automatic guiding balloon catheter and use method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115445059B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116328158A (en) * | 2023-03-25 | 2023-06-27 | 北京仰生恒泰科技有限责任公司 | Head bag body embedded medical catheter |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103298517A (en) * | 2010-09-17 | 2013-09-11 | 雅培心血管系统有限公司 | Length and diameter adjustable balloon catheter |
CN106178231A (en) * | 2016-08-03 | 2016-12-07 | 武汉福脉医疗科技有限公司 | Medical double-deck high pressure resistant sacculus and preparation method thereof |
WO2017199155A1 (en) * | 2016-05-15 | 2017-11-23 | Thermopeutix, Inc. | Variable size balloon catheter for vessel treatment |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0820784B1 (en) * | 1996-07-24 | 2003-06-11 | Cordis Corporation | Balloon catheter and methods of use |
CN101045175B (en) * | 2006-03-29 | 2012-07-04 | 微创医疗器械(上海)有限公司 | Double-layered balloon catheter |
US8784442B2 (en) * | 2011-08-19 | 2014-07-22 | Empirilon Technology, Llc | Methods and systems for performing thrombectomy procedures |
WO2019010244A1 (en) * | 2017-07-03 | 2019-01-10 | Crossbay Medical, Inc. | Apparatus and method for everting catheter with alignment and compliant pressurization |
-
2022
- 2022-10-14 CN CN202211258540.0A patent/CN115445059B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103298517A (en) * | 2010-09-17 | 2013-09-11 | 雅培心血管系统有限公司 | Length and diameter adjustable balloon catheter |
WO2017199155A1 (en) * | 2016-05-15 | 2017-11-23 | Thermopeutix, Inc. | Variable size balloon catheter for vessel treatment |
CN106178231A (en) * | 2016-08-03 | 2016-12-07 | 武汉福脉医疗科技有限公司 | Medical double-deck high pressure resistant sacculus and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN115445059A (en) | 2022-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109381780B (en) | drug-coated balloon catheter | |
JP3773351B2 (en) | Fluid-driven stent delivery system | |
US7300415B2 (en) | Balloon catheter having an external guidewire | |
RU2737289C2 (en) | Catheter system for use in delivery and deployment of intravascular device | |
US5049131A (en) | Balloon catheter | |
CA2360551C (en) | Bifurcation stent delivery system | |
JP3037055B2 (en) | Protective sheath stent delivery system | |
CN109381783B (en) | Drug-coated balloon catheter | |
KR20100098374A (en) | Balloon for the treatment of stenosis and method for manufacturing the balloon | |
JPH1189942A (en) | Catheter assembly and stent supply system | |
CA2511759A1 (en) | Drug delivery balloon catheter | |
CN107835676B (en) | Balloon catheter | |
US20120265236A1 (en) | Catheter device | |
CN110548211B (en) | Medicine balloon catheter with plugging function | |
CN115445059B (en) | Automatic guiding balloon catheter and use method thereof | |
CN104857615A (en) | Novel dual-layer drug balloon catheter | |
EP3513830B1 (en) | Sheath for medically expandable balloon | |
JP2022509927A (en) | Dual balloon catheter and how to use it | |
CN115317766B (en) | Cutting balloon catheter with hidden blades | |
JP2018068724A (en) | Balloon catheter | |
CN114209961A (en) | A kind of medicine balloon dilatation catheter and preparation method thereof | |
US20060135983A1 (en) | Catheter with tapered end balloon | |
CN221655578U (en) | Intracranial balloon dilation catheter | |
CN216653092U (en) | Balloon catheter system | |
US12350450B2 (en) | System and method for controlled delivery of medical devices into patient bodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |